Bellevue, WA, United States of America

Erik Christenson


Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Erik Christenson

Introduction

Erik Christenson is an accomplished inventor based in Bellevue, WA (US), known for his significant contributions to the field of biotechnology. With a total of three patents to his name, he has made notable advancements in the understanding and application of human poly(ADP-ribose) polymerase.

Latest Patents

One of Erik's latest patents is focused on human poly(ADP-ribose) polymerase 2 materials and methods. This invention provides a novel human poly(ADP-ribose) polymerase (hPARP2) polypeptides, polynucleotides encoding the polypeptides, expression constructs comprising the polynucleotides, and host cells transformed with the expression constructs. Additionally, the patent outlines methods for producing the hPARP2 polypeptides, as well as antibodies that are immunoreactive with the hPARP2 polypeptides. Furthermore, it includes methods for identifying specific binding partners of hPARP2, particularly those that modulate the biological activity of hPARP2. The patent also describes methods of modulating biological activity of hPARP2 both in vitro and in vivo.

Another significant patent by Erik involves PARP inhibitors. This invention provides compounds comprising a bicyclic aryl moiety, such as 2H-phthalazin-1-one or derivatives thereof, along with compositions and methods for producing and using these compounds. The patent details compounds of a specific formula, including pharmaceutically acceptable salts, hydrates, solvates, or prodrugs.

Career Highlights

Throughout his career, Erik has worked with notable companies such as Icos Corporation and Deltagen Research Labs, LLC. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Erik has collaborated with several professionals in his field, including David L McElligott and Phyllis S Goldman. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Erik Christenson's innovative work in biotechnology, particularly in the development of hPARP2 and PARP inhibitors, showcases his significant contributions to the field. His patents reflect a deep understanding of molecular biology and its applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…